Sana biotechnology to present at the goldman sachs cell therapy day conference

Seattle, sept. 30, 2024 (globe newswire) -- sana biotechnology, inc. (nasdaq: sana), a company focused on changing the possible for patients through engineered cells, today announced that it will webcast its panel at the goldman sachs cell therapy day conference at 1:00 p.m. et on tuesday, october 1, 2024. the presentation will feature a business overview and update by steve harr, sana's president and chief executive officer.
SANA Ratings Summary
SANA Quant Ranking